MedTrace Logo

A Randomised Controlled Trial of Hysteroscopic Resection of Mild Septum/Arcuate Uteri.

NCT03384082 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 82

Last updated 2020-03-05

No results posted yet for this study

Summary

At least 82 cases of recurrent miscarriage women with a diagnosis of arcuate uterus, confirmed by three-dimensional intra-vaginal sonography (3D-TVS) and hysteroscopy, will be recruited. The subjects will be randomly divided into two groups, the experimental group will be given hysteroscopic treatment, the control group will receive no treatment. The pregnancy rates (\>12 weeks) of the two groups will befollowed and compared.

Conditions

  • Arcuate Uterus

Interventions

PROCEDURE

hysteroscopic treatment

treatment

Sponsors & Collaborators

  • Fu Xing Hospital, Capital Medical University

    lead OTHER

Principal Investigators

  • Dongmei Song, Ph.D · Fuxing Hospital, Capital Medical University

  • Tinchiu Li, Ph.D · Prince of Wales Hospital, Chinese University of Hong Kong

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-22
Primary Completion
2021-01-01
Completion
2022-01-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03384082 on ClinicalTrials.gov